Clinical Trial Update: Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3A [Phase 2]

View source ↗

Summary

This phase 2 trial compares Obinutuzumab with CHOP versus Obinutuzumab with Bendamustine in newly diagnosed Follicular lymphoma Grade 3A. The study status is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Deltasone (prednisone)
• Gazyva (Obinutuzumab)
• Oncovin (vincristine)
• Treanda (Bendamustine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Follicular Lymphoma Grade 3A | Phase 2 | Status: NOT_YET_RECRUITING